Scientific Programme

Pre-Congress
Friday, 21 Nov 2014
Day One
Saturday, 22 Nov 2014
Day Two
Sunday, 23 Nov 2014
Day Three
Monday, 24 Nov 2014

1000 - 1730	Registration and Materials Pick-Up
1000 - 1800	*IDF-WPR Council Meeting
1200 - 1600	Pre-congress Workshop: How to Run an Effective CGMS and Insulin Pump Program. Sponsored by Medtronic Why Insulin Pump Therapy? - Overview of Pump Therapy – Evidence in T1 and T2 - Case studies - Question & Answer Session - Practicum Session (Duration: 50 Mins) Pratik Choudhary How is Pump Therapy Used in Your Centre? - Practicum Session - Best Practice Sharing - Practicum Session (Duration: 50 Mins) Pratik Choudhary The Value of Continuous Glucose Monitoring (CGM) - iPro2 - Intro to iPro2 - Benefits of iPro2 - Essentials of Running an iPro2 Clinic - Reports Interpretation – Adjustments to Current Therapy / Rationale for Insulin Pump Therapy - Question & Answer Session - Practicum Session (Duration: 50 Mins) Pratik Choudhary Best Practices Sharing Running iPro2 and Insulin Pump Programs at Tertiary Level - iPro2 Experience Sharing from Malaysia UMMC (Duration: 20 Mins) Alex Tan - Insulin Pump Experience Sharing from Singapore Khoo Teck Puat Hospital (KTPH) (Duration: 20 Mins) Angela Koh - Experience Sharing from United Kingdom (Duration: 20 Mins) Pratik Choudhary Question & Answer Session	Pre-congress Workshop: Essentials of Bariatric and Metabolic Surgery Sponsored by Ethicon Opening Remarks: Asim Shabbir Video Session: - A brief introduction to current metabolic procedures Laparoscopic sleeve gastrectomy Shah Shashank Laparoscopic Roux en Y gastric bypass Asim Shabbir Laparoscopic gastric band Suthep Udomsawaengsup - Beyond BMI: Patient selection for bariatric and metabolic surgery Khoo Chin Meng - IDF Guidelines for treating diabetes: Appropriate utilization of metabolic surgery – implications of surgery. David Cummings - Common complications of Bariatric surgery Suthep Udomsawaengsup Question & Answer Session Mechanistic insights into obesity & type 2 diabetes from bariatric to metabolic surgery David Cummings Other metabolic procedures: a futuristic insight Lee Wei-Jei Durability of metabolic surgery in morbidly obese diabetic – clinical updates Tham Kwang Wei Metabolic surgery in low BMI Type II diabetic patients: what is the evidence? Shah Shashank
1330 - 1730	*Pre-congress Symposium: Clinical Diabetes Education: How Effective Are We? Organised by Association of Diabetes Educators Singapore (ADES)* Guest Of Honour: Dr Pauline Tan Chief Nursing Officer Ministry of Health, Singapore a. Strategies for change in people with diabetes Julie Seow b. The effectiveness of diabetes education: From research to reality Jo Jo Kwan c. Managing older people with diabetes Trisha Dunning d. Clinical diabetes education in Taiwan Yeh Mei Chang e. Living well with diabetes Heng Pei Yan f. Nocturnal hypoglycaemia in diabetes Winnie Chui
1600 - 2000	Pre-congress Workshop: The Continuum of Insulin Therapy in Type 2 Diabetes Sponsored by Novo Nordisk - Interactive case studies Chantal Mathieu - Coffee break - Insuline in combination with other anti-diabetes agents in advanced type 2 diabetes. Chantal Mathieu - Dinner	Pre-congress Workshop: Nutrition in Diabetes Sponsored by Abbott and Singapore General Hospital (SGH) Introduction: Optimizing diabetes management (role of nutrition) Daphne Gardner Nutritional management of T2D Kala Adaikan Advanced Carbohydrate counting Kala Adaikan Food label reading Switch over with: Identifying nutrients in food and carbohydrate counting Answers review Tea break Principles of DAFNE management 1. DAFNE overview Goh Su-Yen 2. DAFNE eating principles Kala Adaikan 3. Concept of insulin titration Daphne Gardner 4. Sick day rules Lim Huee Boon 5. Physical activity Kala Adaikan 6. Referral Criteria and Wrap up Daphne Gardner

0815 - 0930	Opening Ceremony President's address Guest of Honour's address
0930 - 1015	Presidential Plenary Lecture 1 (IDF-WPR) "An Asian diabetes phenotype, or a phenotype in transition?" Juliana Chan
1015 - 1030	Coffee Break and Industry Exhibition
1030 - 1230	Clinical Diabetes and Therapeutics 1 (IDF-WPR / AASD)	Clinical Diabetes and Therapeutics 2 (IDF-WPR / AASD)	Behavioural Medicine, Clinical Nutrition, Education & Exercise (IDF-WPR)	Basic Science, Aetiology and Mechanism of Disease (AASD)	Poster Presentations
	Symposium 1: Clinical therapeutics/Treatment algorithms	Symposium 2: Type 1 Diabetes	Symposium 3: Nutritional Strategies in Glycemic and Weight Management	Symposium 4: Systems Biology of Diabetes Mellitus	Posters will be classified by topic and displayed throughout entire duration of congress Authors are encouraged to be at their posters at poster breaks and lunch breaks
	a. Diabetes therapeutics: a perspective on trials Hertzel Gerstein	a. Autoimmunity and anti-inflammatory therapy in Type 1 diabetes Bernhard Otto Boehm	a. The role of low GI foods in glycemic control Jeyakumar Henry	a. The epigenome and its role in diabetes Takashi Kadowaki
	b. On the horizon-a critical look at SGLT-2 inhibitors Gregory Fulcher	b. Exercise management in diabetes Paul Fournier	b. Nutrition and diabetes- roles of nutrient and other biomarkers in disease prediction Xu Lin	b. Ethnic differences in genome-wide association studies Tai E Shyong
	c. New basal insulins – the longer the better? Chantal Mathieu	c. Is islet transplantation still a cure for Type 1 diabetes? Per-Olof Berggren	c. Protective strategies in nutrition for the management of diabesity Widjaja Lukito	c. Metabolomics in diabetes mellitus Jean-Paul Kovalik
	d. Inpatient glycemic management – what endocrinologists and hospital administrators need to know? Francisco Pasquel	d. Are we ready to "close the loop"? Pratik Choudhary	d. Optimal nutrition for weight management John Dixon	d. Phosphoproteomic analysis of insulin resistance David James
1230 - 1400	Pharma Lunch Symposium 1: Sponsored by BI-Lilly Alliance The evolving paradigm in T2D treatment – Targeting the pathogenesis of T2D early with contemporary and complementary therapeutic strategies Chairman: Lee Chung Horn Welcome & Opening Remarks: Lee Chung Horn Topic 1 - Uncontrolled HbA1c with metformin: Pathophysiological considerations in choosing second-line treatment Lawrence Leiter Topic 2 - Understanding the value of glycosuria through SGLT2 inhibition Ted Wu Closing Remarks and Summary: Lee Chung Horn	Pharma Lunch Symposium 2: Sponsored by Janssen Where do SGLT2 inhibitors fit in type 2 diabetes care? "SGLT2 inhibitors in type 2 diabetes treatment" Gregory Fulcher "Managing type 2 diabetes in the Asian population" Juliana Chan "Case study and discussion" Gregory Fulcher Juliana Chan Sum Chee Fang	Pharma Lunch Symposium 3: Sponsored by Novo Nordisk "From bench to bedside: the journey to advance insulin therapy"; Chantal Mathieu "Therapies in the continuum of DM care: rationale and evidence". Ronald Goldenberg	Pharma Lunch Symposium 4: Sponsored by Servier Optimising glycaemic control to protect renal and cardiovascular - Findings from ADVANCE-ON. "Diabetes and vascular outcomes: Learning from the morbi-mortality trials" Chan Siew Pheng "Lessons from ADVANCE-ON" Sophia Zoungas Questions & Answers
1415 - 1530	Oral Presentations: Behavioural Interventions and Management Tools	Oral Presentations: Therapeutics – Oral and Novel Agents	Oral Presentations: Diabetes in Different Communities	Oral Presentations: Nephropathy – Basic & Experimental Science
1530 - 1615	Coffee Break, Industry Exhibitions and Presidential Posters				1530 - 1630 Presidential Posters Selected 'presidential' posters will be presented over one hour to a gathered audience Moderated by an appointed chairman
1615 - 1715	Evening Symposium 1: Diabetes and Pregnancy	Evening Symposium 2: Debate: Using HbA1c to Diagnose Diabetes is Neither Helpful, Nor is it Accurate	Evening Symposium 3: Coping with the Epidemic Of Diabetes: the Role of Public Policy	Evening Symposium 4: Emerging Data on Adipose Tissue in Diabetes and Obesity
	a. HAPO study: what’s new? Jeremy Oats	a. Proposition Jaime Davidson	a. Epidemic obesity and the rise of Type 2 diabetes in Asia Yoon Kun-Ho	a. Adipose tissue inflammation and B regulatory cell dysfunction Takashi Kadowaki
	b. Should we adopt the IADPSG criteria for gestational diabetes? Hung Yuan Li	b. Opposition Jonathan Shaw	b. Tackling diabetes in Asia: a multi-sectorial approach Chia Kee Seng	b. Genetic determinants of Type 2 diabetes and its complication in Chinese and East Asian populations Hu Cheng
		c. Moderator Lee Chung Horn

0800 - 0845	IDF Regional Award Ceremony Citation by Chair, IDF-WPR Prof Nam Han Cho Presentation of Award to Prof Yutaka Seino and Acceptance Speech
0845 - 0930	Presidential Plenary Lecture 2 (AASD) A Journey to Elucidate the Insulin Signalling Network for Understanding Diabetes Masato Kasuga
0930 - 0945	Coffee Break and Industry Exhibition
0945 - 1215	Clinical Diabetes and Therapeutics 1 (IDF-WPR / AASD)	Clinical Diabetes and Therapeutics 2 (IDF-WPR / AASD)	Behavioural Medicine, Clinical Nutrition, Education & Exercise (IDF-WPR)	Basic Science, Aetiology and Mechanism of Disease (AASD)	Poster Presentations
	Symposium 5: Your Patient has Diabetic Complications - Now What?	Symposium 6: Diabetes in Children/Adolescents	Symposium 7: Lifestyle Interventions in Diabetes Prevention	Symposium 8: Adiponectin Biology	Posters will be classified by topic and displayed throughout entire duration of congress Authors are encouraged to be at their posters at poster breaks and lunch breaks
	a. Novel pharmacotherapies in diabetic retinopathy Wong Tien Yin	a. Key points in 2013 American Academy of Pediatrics CPG on management of Type 2 diabetes mellitus in children and adolescents Kenneth Copeland	a. A new equation to estimate basal energy expenditure of patients with diabetes Nobuya Inagaki	a. Adiponectin in the regulation of metabolism William Wong
	b. The usefulness of glucose and lipid control in nephropathy and retinopathy Jonathan Shaw	b. Early life influences and diabetes Wayne Cutfield	b. Sedentary Behaviour and Physical Activity in Prevention of Diabetes Mueller-Riemenschneider Falk	b. Adiponectin, FGF21 and metabolic homeostasis Aimin Xu
	c. Improving outcome of diabetic dialysis patients: a burden shared by the endocrinologist and nephrologist Titus Lau Wai Leong	c. Gestational diabetes and the NCD epidemic Ronald Ma	c. Nutrition in diabetes prevention Rob van Dam	c. Adiponectin signal transduction Feng Liu
	d. New therapies for diabetic neuropathy Umapathi Thirugnanam	d. Type 1 diabetes mellitus in preschool children Ragnar Hanas	d. Implementation of population-wide preventive strategies for diabetes Shyamala Thilagaratnam	d. Adiponectin in tissue defenses Iichiro Shimomura
	e. Screening for diabetic retinopathy Ecosse Lamoureux	e. Monogenic diabetes – undiagnosed and untreated Daphne Gardner	e. Diabetes prevention in India Ambady Ramachandran
1230 - 1400	Pharma Lunch Symposium 1: Sponsored by Astra-Zeneca Opening Remarks: Ji Linong "Diabetes in Asia: How are We Different" Augusto G. Litonjua "Incretin modifying medications: What do We Know?" Jaime Davidson "New Medications on the Horizon: SGLT2 Inhibitors" Naoto Nakamura Q&A Session and Closing	Pharma Lunch Symposium 2: Sponsored by Roche Mobile Connectivity and Diabetes eHealth David Kerr	Pharma Lunch Symposium 3: Sponsored by MSD “DPP-4 Inhibitors: Have We Optimized Their Role in the Treatment of Patients With Type 2 Diabetes?” Welcome by Chair: Chee Eng Tan Have we Optimized the Role of DPP-4 Inhibitors in the Treatment of Type 2 Diabetes? Yoon Kun Ho Q&A CVOT and Implications for the Future of Treatment of Type 2 Diabetes Timothy Davis Q&A Faculty Panel Discussion Closing Comments: Chee Eng Tan	Pharma Lunch Symposium 4 Sponsored by Eli-Lilly Advancement in GLP-1 Receptor Agonists therapy for Improved T2DM Patient Care Welcome & Introduction: Tai E-Shyong Diabetes and unmet needs: Current treatment options on GLP-1 receptor agonist Stephen Gough Weekly GLP-1 Receptor Agonist: Emerging Scientific Data Mathijs Bunck Panel Discussion
1415 - 1530	Oral Presentations: Microvascular Complications	Oral Presentations: Clinical Diabetes	Oral Presentations: Macrovascular Disease	Oral Presentations: Metabolic Regulation
1530 - 1615	Coffee Break, Industry Exhibitions and Presidential Posters				1530 - 1630 Presidential Posters Selected 'presidential' posters will be presented over one hour to a gathered audience Moderated by an appointed chairman
1615 - 1715	Evening Symposium 5: Hypoglycaemia	Evening Symposium 6: Diabetes and Cardiovascular Disease	Evening Symposium 7: Health Literacy in Diabetes	Evening Symposium 8: Incretin Biology
	a. Drivers of hypoglycaemia and education strategies for prevention Jane Speight	a. DPP 4 inhibitors CV trials Lawrence Leiter	a. A review of health literacy: problems, tools and interventions How Choon How	a. Incretin actions beyond the pancreas: lessons from knockout mice Yutaka Seino
	b. Using technology to reduce hypoglycaemia risk Pratik Choudhary	b. A reflection on the 2013 ACC/AHA lipid guidelines: helpful or problematic? Tai E Shyong	b. Health literacy and the managing diabetes in India: paradigms in outcomes Shaukat Sadikot	b. Incretin-based therapies: Why so effective in Asians? Daisuke Yabe

0830 - 1030	Clinical Diabetes and Therapeutics 1 (IDF-WPR / AASD)	Clinical Diabetes and Therapeutics 2 (IDF-WPR / AASD)	Behavioural Medicine, Clinical Nutrition, Education & Exercise (IDF-WPR)	Basic Science, Aetiology and Mechanism of Disease (AASD)	Poster Presentations
	Symposium 9: National Diabetes Care Models: Perspective from ASEAN Countries	Symposium 10: Management of Obesity	Symposium 11: Economic Evaluation in Diabetes	Symposium 12: Islet Cell Biology	Posters will be classified by topic and displayed throughout entire duration of congress Authors are encouraged to be at their posters at poster breaks and lunch breaks
	a. Philippines Elizabeth Paz-Pacheco	a. Bariatric surgery: Why, when and which for the Asian phenotype Lee Wei-Jei	a. Simulation-based cost effectiveness analyses: The updated UPKDS Outcomes Model Philip Clarke	a. Emerging data in islet biology for autoimmune diabetes Bernhard Otto Boehm
	b. Singapore Lee Chung Horn	b. Cost-effectiveness of bariatric surgery for diabetes management Eric Andrew Finkelstein	b. Economic modelling from the decision maker’s perspective Kelvin Bryan Tan	b. Update on islet Imaging Per-Olof Berggren
	c. Malaysia Chan Siew Pheng	c. Innovative strategies: lessons from bariatric surgery John Dixon	c. Cost-effectiveness of pen versus vial/syringe administration of premixed insulin Wee Hwee-Lin	c. Glucolipotoxicity in the Beta Cell Trevor Biden
	d. Vietnam Nguyen Thy Khue	d. Clinical trials in metabolic surgery: lessons learnt and what needs to be done David Cummings	d. Current status of care and costs of type 1 diabetes in China–report form 3C study Ji Linong	d. Insulin granule trafficking Han Wei Ping
	e. Thailand Pongamorn Bunnag
	f. Indonesia Achmad Rudijanto Cholil
1030 - 1045	Coffee Break and Industry Exhibition
1045 - 1200	Oral Presentations: Therapeutics – Oral Agents	Oral Presentations: Cost-Effective Health Care and Outcomes	Oral Presentations: Genetics	Oral Presentations: Nephropathy – Clinical & Translational Research
1200 - 1400	Lunch
1415 - 1530	Oral Presentations: Obesity and Metabolic Syndrome	Oral Presentations: Nutrition & Diabetes	Oral Presentations: Insulin Treatment and Islet Cell Signalling	Oral Presentations: Insulin Resistance
1530 - 1615	Coffee Break, Industry Exhibitions and Presidential Posters				1530 - 1630 Presidential Posters Selected 'presidential' posters will be presented over one hour to a gathered audience Moderated by an appointed chairman
1615 - 1715	Evening Symposium 9: Diabetic Foot Management	Evening Symposium 10: Technology and Diabetes	Evening Symposium 11: Self-Management and Patient Empowerment in Diabetes Care	Evening Symposium 12: Maternal Environment in Diabetes and Metabolic Disease
	a. Inpatient management of patients with diabetic foot infections Shigeo Kono	a. Self blood glucose monitoring: new vistas, new paradigms Wayne Sheu	a. Adaptive cultural change: how China educates her billion about diabetes Ji Linong	a. Emerging data about ARNT and other transcription factors in gene expression and islet dysfunction in Type 2 diabetes and gestational diabetes Jenny Gunton
	b. Management of the diabetic foot in Thailand Thep Himathongkam	b. "Actionable" SMBG for patients using insulin David Kerr	b. Education as prescription in type 2 diabetes subjects: complince with efficacy in clinical practice Lee Moon-Kyu	b. Epigenetic programming in metabolic disease Walter Stunkel
1800 - 1830	Closing Ceremony

The programme may be subject to some modification and is accurate as of 20 November 2014.

*IDF-WPR Council Meeting is by invite only.
**Please be advised that this pre-congress symposium requires separate registration and fee. Those interested to attend can email us at .


			Hosted by	Held in


Supported by
		Chapter of Endocrinologists College of Physicians, Singapore